EC Healthcare (HK:2138) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EC Healthcare has reported a mixed financial outlook for the April to June 2024 quarter, with an overall decrease in sales volume by up to 4% compared to the previous year. Notably, aesthetic medical and wellness services in Mainland China saw a significant decline by up to 51%, while sales in other services increased by at least 10%. Investors are urged to exercise caution as these figures are based on preliminary unaudited management accounts.
For further insights into HK:2138 stock, check out TipRanks’ Stock Analysis page.